Akums breaks ground for its first overseas manufacturing facility in Zambia
It will produce a comprehensive range of dosage forms including tablets, hard gelatin capsules, liquids, injectables, topicals, and beta-lactam products
It will produce a comprehensive range of dosage forms including tablets, hard gelatin capsules, liquids, injectables, topicals, and beta-lactam products
Cadila Pharmaceuticals has introduced Dlorfast-M-Tablets as a dual-action therapy that targets two key pathways of allergic response
Medico Remedies receives order worth US$ 1,781,000
Pioneering innovation aims to transform anticoagulant therapy and improve patient outcomes
With global certification in place, the Ambernath site expands Supriya’s footprint beyond APIs into high-margin formulations
An estimated 50% of patients with ER+, HER2– metastatic breast cancer will develop an ESR1 mutation during or after exposure to an aromatase inhibitor
Relonchem receives marketing authorization for Moxonidine tablets
The Phase Ib MAD study is a randomized, double-blind, placebo-controlled trial conducted in the United States
Subscribe To Our Newsletter & Stay Updated